Literature DB >> 7749630

The cerebral expression of plasma protein genes in different species.

A R Aldred1, C M Brack, G Schreiber.   

Abstract

The cerebrospinal fluid (CSF) contains the same proteins as blood plasma, but with a different pattern of concentrations. Protein concentrations in CSF are much lower than those in blood. CSF proteins are derived from blood or synthesized within the brain. The choroid plexus is an important source of CSF proteins. Transthyretin is the protein most abundantly synthesized and secreted by choroid plexus. It determines the distribution of thyroxine in the cerebral compartment. Synthesis of transthyretin first evolved in the brain, then later it became a plasma protein synthesized in the liver. Other proteins secreted by choroid plexus are serum retinol-binding protein, transferrin, caeruloplasmin, insulin-like growth factors, insulin-like growth factor binding proteins, cystatin C, alpha 1-antichymotrypsin, alpha 2-macroglobulin, prothrombin, beta 2-microglobulin and prostaglandin D synthetase. Species differences in expression of the genes for these proteins are outlined, and their developmental pattern, regulation and roles in the cerebral extracellular compartment are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7749630     DOI: 10.1016/0305-0491(94)00229-n

Source DB:  PubMed          Journal:  Comp Biochem Physiol B Biochem Mol Biol        ISSN: 1096-4959            Impact factor:   2.231


  31 in total

Review 1.  Toxicology of choroid plexus: special reference to metal-induced neurotoxicities.

Authors:  W Zheng
Journal:  Microsc Res Tech       Date:  2001-01-01       Impact factor: 2.769

2.  The blood-CSF barrier in culture. Development of a primary culture and transepithelial transport model from choroidal epithelial cells.

Authors:  Wei Zheng; Qiuqu Zhao
Journal:  Methods Mol Biol       Date:  2002

3.  Inhibition by lead of production and secretion of transthyretin in the choroid plexus: its relation to thyroxine transport at blood-CSF barrier.

Authors:  W Zheng; W S Blaner; Q Zhao
Journal:  Toxicol Appl Pharmacol       Date:  1999-02-15       Impact factor: 4.219

4.  Ceruloplasmin gene expression in the murine central nervous system.

Authors:  L W Klomp; Z S Farhangrazi; L L Dugan; J D Gitlin
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

5.  Transthyretin-derived peptides as β-amyloid inhibitors.

Authors:  Patricia Y Cho; Gururaj Joshi; Jeffrey A Johnson; Regina M Murphy
Journal:  ACS Chem Neurosci       Date:  2014-04-09       Impact factor: 4.418

6.  Alteration of cystatin C levels in cerebrospinal fluid of patients with Guillain-Barré Syndrome by a proteomical approach.

Authors:  Yinrong Yang; Shilian Liu; Zhaoyu Qin; Yazhou Cui; Yanjiang Qin; Shumei Bai
Journal:  Mol Biol Rep       Date:  2008-03-29       Impact factor: 2.316

7.  Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity.

Authors:  Kayla M Pate; Regina M Murphy
Journal:  Isr J Chem       Date:  2017-01-18       Impact factor: 3.333

8.  Culture of choroid plexus epithelial cells and in vitro model of blood-CSF barrier.

Authors:  Andrew D Monnot; Wei Zheng
Journal:  Methods Mol Biol       Date:  2013

9.  Prothrombin in normal human cerebrospinal fluid originates from the blood.

Authors:  P Lewczuk; H Reiber; H Ehrenreich
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

10.  Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.

Authors:  Chera L Maarouf; Thomas G Beach; Charles H Adler; Holly A Shill; Marwan N Sabbagh; Terence Wu; Douglas G Walker; Tyler A Kokjohn; Alex E Roher
Journal:  Neurol Res       Date:  2012-09       Impact factor: 2.448

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.